IDEXX Laboratories, Inc.
IDXX
$491.70
$1.720.35%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 3.93B | 3.90B | 3.84B | 3.78B | 3.72B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.93B | 3.90B | 3.84B | 3.78B | 3.72B |
| Cost of Revenue | 1.52B | 1.52B | 1.51B | 1.50B | 1.48B |
| Gross Profit | 2.41B | 2.38B | 2.33B | 2.29B | 2.24B |
| SG&A Expenses | 914.11M | 907.80M | 885.61M | 933.67M | 925.46M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.66B | 2.65B | 2.61B | 2.64B | 2.61B |
| Operating Income | 1.27B | 1.25B | 1.23B | 1.14B | 1.12B |
| Income Before Tax | 1.12B | 1.11B | 1.09B | 1.06B | 1.09B |
| Income Tax Expenses | 229.47M | 221.96M | 226.87M | 216.47M | 222.40M |
| Earnings from Continuing Operations | 894.97 | 887.87 | 866.24 | 845.63 | 866.57 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 894.97M | 887.87M | 866.24M | 845.63M | 866.57M |
| EBIT | 1.27B | 1.25B | 1.23B | 1.14B | 1.12B |
| EBITDA | 1.40B | 1.38B | 1.36B | 1.27B | 1.23B |
| EPS Basic | 10.91 | 10.77 | 10.47 | 10.19 | 10.43 |
| Normalized Basic EPS | 9.50 | 9.34 | 9.19 | 8.46 | 8.19 |
| EPS Diluted | 10.82 | 10.67 | 10.36 | 10.09 | 10.32 |
| Normalized Diluted EPS | 9.42 | 9.26 | 9.10 | 8.38 | 8.11 |
| Average Basic Shares Outstanding | 328.10M | 329.88M | 331.12M | 331.91M | 332.37M |
| Average Diluted Shares Outstanding | 330.91M | 332.94M | 334.34M | 335.28M | 335.87M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |